Clinical Investigation Plan for IQon Spectral CT at Utrecht Medical Center (UMC)
NCT ID: NCT02747095
Last Updated: 2017-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
980 participants
INTERVENTIONAL
2016-01-31
2017-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In addition to the aim mentioned above, the investigators would like to develop recommendations for the clinical application of the spectral images in routine use. Such recommendations could include optimization of scanning protocols, optimization of reconstruction parameters; evaluate the utility of iodine maps and other supported materials.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Cardiac Imaging Techniques for Diagnosing Coronary Artery Disease
NCT01521468
Application of speCtraL Computed tomogrAphy to impRove specIficity of Cardiac compuTed tomographY
NCT03139006
Preliminary Assessment of Added Diagnostic Value of Dual Energy CT Images Using Data Acquired on a Spectral Detector CT
NCT02760706
Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography
NCT03292354
Medical Evaluation of Scanner in Coronary Syndrome
NCT00709709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The IQon Spectral CT generates two result types:
* Conventional CT images which are equivalent to images produced by the commercially available Brilliance iCT scanner
* Spectral CT images which are unique to this product.
The CT examination would be a standard of care CT performed as per the clinical indication.
In addition to the aim mentioned above, the investigators would like to develop recommendations for the clinical application of the spectral images in routine use. Such recommendations could include optimization of scanning parameters, optimization of reconstruction parameters to utilize the capabilities of the IQon system etc.
The clinical system includes:
* The IQon Spectral CT scanner
* Spectral Diagnostic suite (Philips IntelliSpace Portal): includes 5 applications. Spectral Enhanced CT Viewer, Spectral Enhanced Advanced Analysis, Spectral Enhanced Comprehensive Cardiac Analysis, Spectral Enhanced Tumor Tracking, spectral magic glass on PACS.
The testing will be conducted under this project plan. This is a single center research study that is expected to be conducted over a one year period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Spectral CT image
Interventions: IQon Spectral CT
IQon Spectral CT
Using IQon Spectral CT, Assess the added diagnostic value and impact on workflow of spectral images
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IQon Spectral CT
Using IQon Spectral CT, Assess the added diagnostic value and impact on workflow of spectral images
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UMC Utrecht
OTHER
Philips Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tim Leiner
Role: PRINCIPAL_INVESTIGATOR
Utrect Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Utrecht Medical Center
Utrecht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DHF246925
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.